Detalhe da pesquisa
1.
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study.
Haematologica
; 109(4): 1184-1193, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646659
2.
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.
J Oncol Pharm Pract
; 30(1): 151-158, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097891
3.
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
J Oncol Pharm Pract
; : 10781552231224361, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166529
4.
Atomic force microscopy measurements and model of DNA bending caused by binding of AraC protein.
J Mol Recognit
; 36(1): e2993, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112092
5.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Haematologica
; 108(1): 98-109, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833303
6.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
7.
Making sense of adaptive expertise for frontline clinical educators: a scoping review of definitions and strategies.
Adv Health Sci Educ Theory Pract
; 27(5): 1213-1243, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302908
8.
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 790-800, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989558
9.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
10.
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.
Blood
; 141(2): 200-203, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332185
11.
Becoming adaptive experts in an era of rapid advances in generative artificial intelligence.
Med Teach
; 46(3): 300-303, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092006
12.
Idées audacieuses: Les 4 meilleures propositions présentées au Forum en médecine familiale 2023.
Can Fam Physician
; 70(2): 91-93, 2024 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-38383020
13.
Big ideas: Top 4 proposals presented at Family Medicine Forum 2023.
Can Fam Physician
; 70(2): 87-88, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383022
14.
Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA.
Emerg Infect Dis
; 24(5): 893-897, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29664369
15.
Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
J Med Virol
; 95(8): e29027, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548241
16.
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.
Haematologica
; 108(12): 3433-3437, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259597
17.
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy.
Ann Hematol
; 102(2): 461-462, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385650
18.
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance.
J Cancer Educ
; 32(3): 647-654, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26897634
19.
Association of Physician Certification in Interventional Cardiology With In-Hospital Outcomes of Percutaneous Coronary Intervention.
Circulation
; 132(19): 1816-24, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384518
20.
Using Kane's framework to build a validity argument supporting (or not) virtual OSCEs.
Med Teach
; 43(9): 999-1004, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33834949